Bextra® Lawyer

On April 7, 2005, Pfizer announced an immediate Bextra® recall. Bextra® is a prescription painkiller prescribed for patients suffering from arthritis, needing acute pain management, or who suffer severe menstrual symptoms, is in a class of drugs called nonsteroidal anti-inflammatory drugs (NSAIDs).

The Bextra® recall comes after months of congressional testimony about the efficacy of the FDA and its ability to protect the public from dangerous drugs in the wake of the Vioxx® withdrawal.

The FDA said the health risks associated with Bextra® outweigh the drug’s benefits. They concluded that Bextra® has an increased risk of cardiovascular (CV) events with long-term use. Their conclusion is supported by the significant rise in CV risk seen in patients who had recently undergone heart surgery.

Contact us today if you or a loved one has been injured or killed through the use of Bextra® by using the form on your left or by calling us toll-free at 1 (866) 664-0400 for a FREE case review.

Bextra® first gained FDA approval in November 2001. An estimated 7 million patients worldwide have taken Bextra® with 12.9 million prescriptions written in 2005.